Stroke - How large a public health problem, and how can the neurologist help?

被引:106
作者
Hankey, GJ [1 ]
机构
[1] Royal Perth Hosp, Dept Neurol, Stroke Unit, Perth, WA 6001, Australia
关键词
D O I
10.1001/archneur.56.6.748
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Stroke is an enormous public health problem, the magnitude of which can be reduced mainly by effective stroke prevention and less so by effective treatment of acute stroke. The greatest effect is likely to he achieved by a mass approach to prevention, which consists of modification of lifestyle behaviors (eg, less smoking and less intake of salt, alcohol, and fat) among the general population through public education and, more importantly, government legislation. The appropriate identification and treatment of high-risk individuals by neurologists is likely to have a smaller but complimentary impact on the population burden of stroke and a substantial impact on the burden of stroke: among individuals; The most cost-effective interventions for patients with transient ischemic attack and ischemic stroke are organized multidisciplinary acute care and rehabilitation in a stroke unit and early secondary prevention with aspirin,: blood pressure control, smoking cessation, and, in the appropriate patient, oral anticoagulant therapy and carotid endarterectomy. The cost-effectiveness of carotid endarterectomy for asymptomatic care rid stenosis is highly questionable until data from ongoing, trials leg, Asymptomatic Carotid Surgery Trial) become available. Screening for asymptomatic carotid stenosis is more likely to be harmful tan helpful, except perhaps among populations with a very high prevalence (pretest probability) of severe carotid stenosis. Iris essential that the impact of these strategies on:the incidence, outcome, and cost of stroke is measured and monitored. Currently;this is:done simply, but unreliably, by examining changes in statistics that are already being measured, such as mortality (eg, among those younger than 70 years old, for greater accuracy). A growing priority in many countries is the development and implementation of valid, reliable,practical, and inexpensive methods of routinely collecting and evaluating data on stroke incidence, outcome, and cost.
引用
收藏
页码:748 / 754
页数:7
相关论文
共 36 条
  • [1] Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia
    Algra, A
    vanGijn, J
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 60 (02) : 197 - 199
  • [2] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
    ALTMAN, R
    CARRERAS, L
    DIAZ, R
    FIGUEROA, E
    PAOLASSO, E
    PARODI, JC
    CADE, JF
    DONNAN, G
    EADIE, MJ
    GAVAGHAN, TP
    OSULLIVAN, EF
    PARKIN, D
    RENNY, JTG
    SILAGY, C
    VINAZZER, H
    ZEKERT, F
    ADRIAENSEN, H
    BERTRANDHARDY, JM
    BRAN, M
    DAVID, JL
    DRICOT, J
    LAVENNEPARDONGE, E
    LIMET, R
    LOWENTHAL, A
    MORIAU, M
    SCHAPIRA, S
    SMETS, P
    SYMOENS, J
    VERHAEGHE, R
    VERSTRAETE, M
    ATALLAH, A
    BARNETT, H
    BATISTA, R
    BLAKELY, J
    CAIRNS, JA
    COTE, R
    CROUCH, J
    EVANS, G
    FINDLAY, JM
    GENT, M
    LANGLOIS, Y
    LECLERC, J
    NORRIS, J
    PINEO, GF
    POWERS, PJ
    ROBERTS, R
    SCHWARTZ, L
    SICURELLA, J
    TAYLOR, W
    THEROUX, P
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921): : 81 - 100
  • [3] [Anonymous], 1994, Transient ischaemic attacks of the brain and eye
  • [4] Asplund K, 1997, BMJ-BRIT MED J, V314, P1151
  • [5] COSTS OF MEDICAL-CARE AFTER FIRST-EVER STROKE IN THE NETHERLANDS
    BERGMAN, L
    VANDERMEULEN, JHP
    LIMBURG, M
    HABBEMA, JDF
    [J]. STROKE, 1995, 26 (10) : 1830 - 1836
  • [6] Carotid stenting and angioplasty - A statement for healthcare professionals from the councils on cardiovascular radiology, stroke, cardio-thoracic and vascular surgery, epidemiology and prevention, and clinical cardiology, American heart association
    Bettmann, MA
    Katzen, BT
    Whisnant, J
    Brant-Zawadzki, M
    Broderick, JP
    Furlan, AJ
    Hershey, LA
    Howard, V
    Kuntz, R
    Loftus, CM
    Pearce, W
    Roberts, A
    Roubin, G
    [J]. STROKE, 1998, 29 (01) : 336 - 338
  • [7] NONINVASIVE CAROTID-ARTERY TESTING - A METAANALYTIC REVIEW
    BLAKELEY, DD
    ODDONE, EZ
    HASSELBLAD, V
    SIMEL, DL
    MATCHAR, DB
    [J]. ANNALS OF INTERNAL MEDICINE, 1995, 122 (05) : 360 - 367
  • [8] Prevalence of stroke and stroke-related disability - Estimates from the Auckland stroke studies
    Bonita, R
    Solomon, N
    Broad, JB
    [J]. STROKE, 1997, 28 (10) : 1898 - 1902
  • [9] INTERNATIONAL TRENDS IN STROKE MORTALITY - 1970-1985
    BONITA, R
    STEWART, A
    BEAGLEHOLE, R
    [J]. STROKE, 1990, 21 (07) : 989 - 992
  • [10] Effect of HMGcoA reductase inhibitors on stroke - A meta-analysis of randomized, controlled trials
    Bucher, HC
    Griffith, LE
    Guyatt, GH
    [J]. ANNALS OF INTERNAL MEDICINE, 1998, 128 (02) : 89 - +